FDC has received an Establishment Inspection Report (EIR) for its manufacturing facility located at B-8, MIDC Industrial Area, Waluj, Aurangabad, Maharashtra, which was inspected from August 10, 2018 to August 16, 2018 by US Food and Drug Administration (USFDA).
The facility is considered to be acceptable with regards to current Good Manufacturing Practices (GMPs) and the inspection stands closed.
FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1842.30 |
| Dr. Reddys Lab | 1278.10 |
| Cipla | 1336.80 |
| Zydus Lifesciences | 932.30 |
| Lupin | 2273.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: